Cancer-related Fatigue Articles

Cancer-related fatigue is a common complaint during cancer treatment and is often associated with cognitive impairment. This study examined cognitive deficits that were associated with fatigue symptoms during external-beam radiation therapy (EBRT) in men with localized prostate cancer.

To evaluate the potential role of levocarnitine supplementation for cancer-related fatigue in patients treated with sunitinib.

Patients treated with sunitinib for unresectable or metastatic renal cell carcinoma were enrolled prospectively.

BACKGROUND - Fatigue is one of the most distressing symptoms experienced by people with cancer receiving radiation therapy.

OBJECTIVES - The goal of this study is to evaluate clinical predictors of worsening fatigue during external beam radiation therapy (EBRT) in men with non-metastatic prostate cancer.

Cancer-related fatigue is one of the most debilitating side effects of cancer and cancer therapy. We aimed to investigate co-occurring symptoms associated with persistent fatigue in men receiving external beam radiation therapy (EBRT) for nonmetastatic prostate cancer.

To explore the fatigue self-management behaviors and factors associated with effectiveness of these behaviors in patients with advanced cancer.
.

Prospective longitudinal interviewer-administered survey.

Testicular germ cell tumours (TGCTs) are the most common malignancy in men aged 15-40 years, with increasing incidence worldwide. About 33 ~ 50% of the patients present with metastatic disease at diagnosis.

Fatigue experienced by cancer patients is one of the most common symptoms with the greatest adverse effect on quality of life, but arguably the least understood. The purpose of this study was to explore changes in integrated mitochondrial function and fatigue in non-metastatic prostate cancer patients receiving localized radiation therapy (XRT).